Koninklijke DSM N.V. Share Price Other OTC
Equities
RDSMY
US7802491081
Consumer Goods Conglomerates
Sales 2024 * | 12.6B 13.47B 1,125B | Sales 2025 * | 13.28B 14.19B 1,185B | Capitalization | 28B 29.92B 2,499B |
---|---|---|---|---|---|
Net income 2024 * | 456M 487M 40.7B | Net income 2025 * | 795M 849M 70.96B | EV / Sales 2024 * | 2.45 x |
Net Debt 2024 * | 2.85B 3.04B 254B | Net Debt 2025 * | 2.58B 2.75B 230B | EV / Sales 2025 * | 2.3 x |
P/E ratio 2024 * |
61.5
x | P/E ratio 2025 * |
35.3
x | Employees | - |
Yield 2024 * |
2.38% | Yield 2025 * |
2.34% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM N.V.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 01/90/01 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 01/23/01 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/23/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 01/23/01 | |
Thomas Leysen
CHM | Chairman | 63 | 01/23/01 |
Director/Board Member | 62 | 01/23/01 |
1st Jan change | Capi. | |
---|---|---|
+13.72% | 888B | |
+1.75% | 244B | |
+25.86% | 175B | |
+1.77% | 140B | |
+78.02% | 102B | |
-8.80% | 71B | |
-7.20% | 56.47B | |
+103.92% | 34.71B | |
+25.34% | 33.2B |